A. Guillygomarc’h

R. Moirand, D. Guyader, C. Le Lan, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results.

M. Rudler, D. Thabut, X. Causse, 2017, Journal of hepatology.

Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial

P. Brissot, A. Guillygomarc’h, F. Laine, 2006, Alimentary pharmacology & therapeutics.

Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing.

P. Brissot, K. Boudjema, R. Moirand, 2002, Journal of hepatology.

The epidemiology of Budd-Chiari syndrome in France.

V. de Lédinghen, O. Farges, D. Valla, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

P0709 : Survival of patients infected by chronic hepatitis c and f0f1 fibrosis at baseline after a 15 years follow-up

R. Moirand, D. Guyader, A. Guillygomarc’h, 2015 .

Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients.

R. Moirand, D. Guyader, A. Guillygomarc’h, 2001, American journal of clinical pathology.

Association of cisplatin and intra-arterial injection of 131I-lipiodol in treatment of hepatocellular carcinoma: results of phase II trial.

K. Boudjema, A. Guillygomarc’h, J. Raoul, 2006, International journal of radiation oncology, biology, physics.

Non‐invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis

P. Brissot, R. Moirand, D. Guyader, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis

K. Boudjema, Y. Rolland, A. Guillygomarc’h, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Letters to the Editor: Non-alcoholic steatohepatitis with iron: part of insulin resistanceassociated hepatic iron overload?

P. Brissot, R. Moirand, A. Guillygomarc’h, 2000 .

Non-alcoholic steatohepatitis with iron: part of insulin resistance-associated hepatic iron overload?

P. Brissot, R. Moirand, A. Guillygomarc’h, 2000, Journal of hepatology.

Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption

P. Brissot, R. Moirand, D. Guyader, 2004, Hepatology.

Use of recombinant factor VIIa to treat persistent bleeding following dental extractions in two cirrhotic patients

A. Guillygomarc’h, A. Berthier, M. Messner, 2002, Vox Sanguinis.

HFE mutations in insulin resistance-associated hepatic iron overload.

R. Moirand, A. Guillygomarc’h, Y. Deugnier, 2000, Journal of hepatology.

Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors

A. Guillygomarc’h, M. Latournerie, A. Brunot, 2014, Cancer Chemotherapy and Pharmacology.

Suspicious liver nodule in chronic liver disease: Usefulness of a second biopsy.

A. Luciani, V. Vilgrain, F. Pilleul, 2018, Diagnostic and interventional imaging.